EMILY BIBLE: Open Payments
NPI 1083365431 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,669 in 151 payments from 16 companies in 2025. Trend: 2023 $1,627 · 2024 $1,667 · 2025 $2,669
Food & beverage: $2,669
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 23 | $330 |
| Amgen Inc. | 23 | $326 |
| Novartis Pharmaceuticals Corporation | 28 | $304 |
| PFIZER INC. | 17 | $278 |
| E.R. Squibb & Sons, L.L.C. | 11 | $274 |
| ABBVIE INC. | 19 | $262 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $226 |
| Arcutis Biotherapeutics, Inc. | 3 | $161 |
| UCB, Inc. | 6 | $152 |
| Regeneron Healthcare Solutions, Inc. | 2 | $151 |
Products named: OTEZLA, CIBINQO, Sotyktu, NEMLUVIO, Winlevi, Zoryve, Bimzelx, LIBTAYO.
Industry payments across IN — which companies pay providers there.
